JAMES GARCHITORENA: Open Payments
NPI 1417258872 · WEST ISLIP, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 53 payments from 14 companies in 2025. Trend: 2023 $1,563 · 2024 $2,373 · 2025 $1,425
Food & beverage: $1,406Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $292 |
| Novartis Pharmaceuticals Corporation | 10 | $238 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $177 |
| Amgen Inc. | 13 | $173 |
| Abbott Laboratories | 2 | $130 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| Boston Scientific Corporation | 4 | $84 |
| Novo Nordisk Inc | 3 | $60 |
| HEARTFLOW, INC. | 2 | $39 |
| PFIZER INC. | 2 | $38 |
Products named: LEQVIO, LifeVest, Repatha, FARXIGA, CARDIOMEMS, LOKELMA, WATCHMAN FLX, VERQUVO.
Industry payments across NY — which companies pay providers there.
